Cascadian Therapeutics, Inc. Common Stock, Value, Issued
Cascadian Therapeutics, Inc. had Common Stock, Value, Issued of $353.85 million as of 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2018-03-08
- 2017-12-31: Common Stock, Value, Issued $353.85M.
- 2017-09-30: Common Stock, Value, Issued $353.85M.
- 2017-06-30: Common Stock, Value, Issued $353.85M.
- 2017-03-31: Common Stock, Value, Issued $353.85M.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2017-12-31 | $353.85M 10-K · filed 2018-03-08 |
| 2017-09-30 | $353.85M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $353.85M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $353.85M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $353.85M 10-K · filed 2018-03-08 |
| 2016-09-30 | $353.86M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $353.86M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $353.86M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $353.86M 10-K · filed 2017-03-09 |
| 2015-09-30 | $353.86M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $353.86M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $353.86M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $353.86M 10-K · filed 2016-03-14 |
| 2014-09-30 | $353.86M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $353.85M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $353.85M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $353.85M 10-K · filed 2015-03-10 |
| 2013-09-30 | $353.85M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $353.85M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $353.85M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $353.85M 10-K · filed 2014-03-13 |
| 2012-09-30 | $353.85M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $353.85M 10-Q · filed 2012-08-13 |
| 2012-03-31 | $353.85M 10-Q/A · filed 2012-08-13 |
| 2011-12-31 | $353.85M 10-K · filed 2013-03-14 |
| 2011-09-30 | $353.85M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $353.85M 10-Q · filed 2011-08-08 |
| 2010-12-31 | $353.85M 10-K/A · filed 2012-08-13 |